Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-08-07
1990-12-18
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549389, 514912, A61K 3135, C07D31192
Patent
active
049786784
ABSTRACT:
Novel 12-halogenated forskolin derivatives, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure utilizing compounds or compositions thereof are disclosed.
REFERENCES:
patent: 4088659 (1978-05-01), Bhat et al.
patent: 4118508 (1978-10-01), Bhat et al.
patent: 4134986 (1979-01-01), Bajwa et al.
patent: 4476140 (1984-10-01), Sears et al.
patent: 4517200 (1985-05-01), Kreutner et al.
patent: 4578399 (1986-03-01), Schorlemmer et al.
patent: 4639446 (1987-01-01), Kosley, Jr. et al.
patent: 4672115 (1987-06-01), Kosley, Jr. et al.
patent: 4673752 (1987-06-01), Kosely, Jr. et al.
patent: 4677103 (1987-06-01), Kosley, Jr. et al.
patent: 4724238 (1988-02-01), Dohadwalla et al.
patent: 4734513 (1988-03-01), Hrib
patent: 4740522 (1988-04-01), Hrib
patent: 4771049 (1988-09-01), Kosley, Jr. et al.
patent: 4871764 (1989-10-01), Shutske
Caprioli et al., "Forskolin Lowers Intraocular Pressure by Reducing Aqueous Inflow", Investigative Ophthamology and Visual Science, 25, 268, 1984.
Catchpole W.
Hoechst-Roussel Pharmaceuticals Inc.
Ikeda Tatsuya
Rollins John W.
LandOfFree
12-halogenated forskolin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 12-halogenated forskolin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 12-halogenated forskolin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425851